These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32317131)

  • 1. Post-finasteride syndrome.
    Pereira AFJR; Coelho TOA
    An Bras Dermatol; 2020; 95(3):271-277. PubMed ID: 32317131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-finasteride syndrome.
    Gray SL; Semla TP
    BMJ; 2019 Aug; 366():l5047. PubMed ID: 31399423
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-finasteride syndrome: a surmountable challenge for clinicians.
    Traish AM
    Fertil Steril; 2020 Jan; 113(1):21-50. PubMed ID: 32033719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent sexual side effects of finasteride for male pattern hair loss.
    Irwig MS; Kolukula S
    J Sex Med; 2011 Jun; 8(6):1747-53. PubMed ID: 21418145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-finasteride syndrome - does it really exist?
    Maksym RB; Kajdy A; Rabijewski M
    Aging Male; 2019 Dec; 22(4):250-259. PubMed ID: 30651009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology.
    Melcangi RC; Caruso D; Abbiati F; Giatti S; Calabrese D; Piazza F; Cavaletti G
    J Sex Med; 2013 Oct; 10(10):2598-603. PubMed ID: 23890183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Lee S; Lee YB; Choe SJ; Lee WS
    Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia.
    Di Loreto C; La Marra F; Mazzon G; Belgrano E; Trombetta C; Cauci S
    PLoS One; 2014; 9(6):e100237. PubMed ID: 24959691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen levels and semen parameters among former users of finasteride with persistent sexual adverse effects.
    Irwig MS
    JAMA Dermatol; 2014 Dec; 150(12):1361-3. PubMed ID: 25229565
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent sexual side effects of finasteride: could they be permanent?
    Canguven O; Talib RA
    J Sex Med; 2013 May; 10(5):1441. PubMed ID: 23421328
    [No Abstract]   [Full Text] [Related]  

  • 11. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
    Said MA; Mehta A
    Curr Urol Rep; 2018 Jun; 19(8):65. PubMed ID: 29909472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent sexual side effects of finasteride: could they be permanent?
    Irwig MS
    J Sex Med; 2012 Nov; 9(11):2927-32. PubMed ID: 22789024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Depression Associated With Finasteride Treatment.
    Pompili M; Magistri C; Maddalena S; Mellini C; Persechino S; Baldessarini RJ
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):304-309. PubMed ID: 33814544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.
    Ganzer CA; Jacobs AR; Iqbal F
    Am J Mens Health; 2015 May; 9(3):222-8. PubMed ID: 24928450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
    Coskuner ER; Ozkan B; Culha MG
    Sex Med Rev; 2019 Apr; 7(2):277-282. PubMed ID: 30301703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study.
    Ali AK; Heran BS; Etminan M
    Pharmacotherapy; 2015 Jul; 35(7):687-95. PubMed ID: 26133534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of gut microbiota composition in post-finasteride patients: a pilot study.
    Borgo F; Macandog AD; Diviccaro S; Falvo E; Giatti S; Cavaletti G; Melcangi RC
    J Endocrinol Invest; 2021 Jun; 44(6):1263-1273. PubMed ID: 32951160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
    Fertig RM; Gamret AC; Darwin E; Gaudi S
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride and androgenic alopecia; from therapeutic options to medical implications.
    Motofei IG; Rowland DL; Tampa M; Sarbu MI; Mitran MI; Mitran CI; Stoian AP; Diaconu CC; Paunica S; Georgescu SR
    J Dermatolog Treat; 2020 Jun; 31(4):415-421. PubMed ID: 30897009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.
    Basaria S; Jasuja R; Huang G; Wharton W; Pan H; Pencina K; Li Z; Travison TG; Bhawan J; Gonthier R; Labrie F; Dury AY; Serra C; Papazian A; O'Leary M; Amr S; Storer TW; Stern E; Bhasin S
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4669-4680. PubMed ID: 27662439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.